Cipla Ltd shares rose 0.82% to ₹1,357.10 on the NSE and BSE, with 1,95,261 shares traded. The Mumbai-based multinational, founded in 1935, produces generic drugs across respiratory, cardiovascular, and oncology segments. Cipla remains a key player in India's pharmaceutical sector, with a portfolio including APIs and OTC products.
Cipla Shares Edge Higher as Pharma Major Trades Steady
Source: Business Today